The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
DIEPSS
antipsychotics
extrapyramidal symptoms
schizophrenia
Journal
Human psychopharmacology
ISSN: 1099-1077
Titre abrégé: Hum Psychopharmacol
Pays: England
ID NLM: 8702539
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
28
10
2022
received:
24
05
2022
accepted:
21
11
2022
pubmed:
4
12
2022
medline:
7
3
2023
entrez:
3
12
2022
Statut:
ppublish
Résumé
Drug-induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug-induced extrapyramidal symptoms observed in patients with schizophrenia and assessed using the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). The participants were 1478 patients with a diagnosis of schizophrenia whose EPS was assessed using the DIEPSS in India, Indonesia, Japan, Malaysia, and Taiwan in the 2016 REAP AP-4 study. The records of the participants were randomly divided into two subgroups: the first for exploratory factor analysis of the eight DIEPSS items, and the second for confirmatory factor analysis. The factor analysis identified three factors: F1 (gait and bradykinesia), F2 (muscle rigidity and tremor), and F3 (sialorrhea, akathisia, dystonia, and dyskinesia). The results suggest that the eight individual items of the DIEPSS could be composed of three different mechanisms: acute parkinsonism observed during action (F1), acute parkinsonism observed at rest (F2), and central dopaminergic mechanisms with pathophysiology other than acute parkinsonism (F3).
Substances chimiques
Antipsychotic Agents
0
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2861Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Akaike, H. (1987). Factor analysis and AIC. Psychometrika, 52(3), 317-332. https://doi.org/10.1007/bf02294359
Baik, J. H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Meur, M. L., & Borrelli, E. (1995). Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377(6548), 424-428. https://doi.org/10.1038/377424a0
Bartlett, M. S. (1951). The effect of standardization on a c2 approximation in factor analysis. Biometrika, 38(3-4), 337-344. https://doi.org/10.1093/biomet/38.3-4.337
Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107(2), 238-246. https://doi.org/10.1037/0033-2909.107.2.238
Bermanzohn, P. C., & Siris, S. G. (1992). Akinesia: A syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Comprehensive Psychiatry, 33(4), 221-232. https://doi.org/10.1016/0010-440X(92)90045-R
Browne, M. W., & Cudeck, R. (1992). Alternative ways of assessing model fit. Sociological Methods & Research, 21(2), 230-258. https://doi.org/10.1177/0049124192021002005
Child, D. (2006). The essentials of factor analysis. Continuum International Publishing Group.
Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56(1), 33-39. https://doi.org/10.1001/archneur.56.1.33
Inada, T. (2009). DIEPSS: A second-generation rating scale for antipsychotic-induced extrapyramidal symptoms: Drug-induced Extrapyramidal Symptoms Scale. Seiwa Shoten.
Kaiser, H. F. (1970). A second-generation little jiffy. Psychometrika, 35(4), 401-415. https://doi.org/10.1007/BF02291817
Kaiser, H. F. (1974). An index of factorial simplicity. Psychometrika, 39(1), 31-36. https://doi.org/10.1007/BF02291575
Kim, J. H., Jung, H. Y., Kang, U. G., Jeong, S. H., Ahn, Y. M., Byun, H. J., Ha, K.-S., & Kim, Y. S. (2002). Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): A practical combined rating scale for drug-induced movement disorders. Movement Disorders, 17(6), 1354-1359. https://doi.org/10.1002/mds.10255
Kolbe, H., Clow, A., Jenner, P., & Marsden, C. D. (1981). Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology, 31(4), 434-439. https://doi.org/10.1212/wnl.31.4.434
Loonen, A. J., & Ivanova, S. A. (2021). Neurobiological mechanisms associated with antipsychotic drug-induced dystonia. Journal of Psychopharmacology, 35(1), 3-14. https://doi.org/10.1177/0269881120944156
MacCallum, R. C., & Hong, S. (1997). Power analysis in covariance structure modeling using GFI and AGFI. Multivariate Behavioral Research, 32(2), 193-210. https://doi.org/10.1207/s15327906mbr3202_5
Meyer, JM. (2016). Forgotten but not gone: New developments in the understanding and treatment of tardive dyskinesia. CNS Spectrums, 21(S1), 13-24. https://doi.org/10.1017/S1092852916000730
Polychronis, S., Nasios, G., Dardiotis, E., Messinis, L., & Pagano, G. (2022). Pathophysiology and symptomatology of drooling in Parkinson's disease. Healthcare (Basel), 10(3), 516. https://doi.org/10.3390/healthcare10030516
Salem, H., Nagpal, C., Pigott, T., & Teixeira, A. L. (2017). Revisiting antipsychotic-induced akathisia: Current issues and prospective challenges. Current Neuropharmacology, 15(5), 789-798. https://doi.org/10.2174/1570159X14666161208153644
Srivanitchapoom, P., Pandey, S., & Hallett, M. (2014). Drooling in Parkinson's disease: A review. Parkinsonism & Related Disorders, 20(11), 1109-1118. https://doi.org/10.1016/j.parkreldis.2014.08.013
Winograd-Gurvich, C., Fitzgerald, P. B., Georgiou-Karistianis, N., Bradshaw, J. L., & White, O. B. (2006). Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease. Brain Research Bulletin, 70(4), 312-321. https://doi.org/10.1016/j.brainresbull.2006.06.007